CompletedNot applicableNCT04466293

Choice Architecture Based TB Preventive Therapy Prescribing

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins University
Principal Investigator
Christopher Hoffmann, MD, MPH
Johns Hopkins University
Intervention
Choice Architecture(behavioral)
Enrollment
57 enrolled
Eligibility
All sexes
Timeline
20212022

Study locations (3)

Collaborators

KNCV Tuberculosis Foundation · Clinton Health Access Initiative, Zimbabwe · Aurum Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04466293 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials